Home LiteratureArticle Details
PMID: 22948 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Analysis of the major histocompatibility complex in Syrian hamsters. II. Linkage studies.

Transplantation ·Vol. 25 ·No. 1 ·1978-01-00 ·Pages 17-22

Duncan WR, Streilein JW

Abstract

The genetic control of the histocompatibility antigens that induce strong alloreactions in Syrian hamsters was examined. Genetic studies revealed that the alloantigens involved in skin graft rejection, graft-versus-host reactions, and mixed lymphocyte reactions are under dominant single gene control and that these genetic loci are closely linked. These data suggest that this strong histocompatibility locus (i) may represent the major histocompatibility complex equivalent in this species, and this locus or group of loci has been called Hm-1. In addition, studies concerning the genetic control of the immune response to bovine serum albumin suggest that the high response is under dominant, single gene control; however, this gene is not linked to Hm-1.

MeSH Terms
Animals Cricetinae/immunology Female Genes Genes, MHC Class II Genetic Linkage Graft Rejection Graft vs Host Reaction Histocompatibility Histocompatibility Antigens/genetics Lymphocyte Culture Test, Mixed Male Mesocricetus/genetics,immunology Serum Albumin, Bovine/immunology Skin Transplantation Species Specificity
Chemicals
Histocompatibility Antigens Serum Albumin, Bovine
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Duncan W R
Streilein J W
Article Info
Journal
Transplantation
Abbr.
Transplantation
ISSN
0041-1337
Published
1978-01-00
Pages
17-22
Language
English
Region
United States
NLM ID
0132144
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com